Ligand profile
ZINC3869392
Virtual-screening candidate from ZINC.
Bound to: VK055_5041 — imidazole glycerol phosphate synthase, glutamineamidotransferase subunit
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC3869392- UniProt (similar protein)
Q9X0C8- Tanimoto
- 0.639
- Target protein
- VK055_5041
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 203.4
- −1 ≤ LogP ≤ 5 -2.71
- MW ≤ 500 Da 338.2
- LogP ≤ 5 -2.71
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 203.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
NC(=O)c1ncn([C@H]2O[C@@H](COP(=O)(O)O)[C@@H](O)[C@@H]2O)c1NNC(=O)c1ncn([C@H]2O[C@@H](COP(=O)(O)O)[C@@H](O)[C@@H]2O)c1N
InChI=1S/C9H15N4O8P/c10-7-4(8(11)16)12-2-13(7)9-6(15)5(14)3(21-9)1-20-22(17,18)19/h2-3,5-6,9,14-15H,1,10H2,(H2,11,16)(H2,17,18,19)/t3-,5+,6-,9-/m0/s1InChI=1S/C9H15N4O8P/c10-7-4(8(11)16)12-2-13(7)9-6(15)5(14)3(21-9)1-20-22(17,18)19/h2-3,5-6,9,14-15H,1,10H2,(H2,11,16)(H2,17,18,19)/t3-,5+,6-,9-/m0/s1
NOTGFIUVDGNKRI-HFXAWCPLSA-NNOTGFIUVDGNKRI-HFXAWCPLSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- GUO
- Homolog
- Q9X0C8
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC3869392 →
- ZINC ZINC20 ZINC3869392 →
- UniProt UniProt Q9X0C8 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC3869392”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_5041.
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).